{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fidpodcast.simplecast.com%2Fepisodes%2Fcarbapenem-resistance-revisited-0ywubuIB","width":444,"version":"1.0","type":"rich","title":"Carbapenem Resistance Revisited: Reassessing Our Antibiotics of Choice","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/e5597b3c-dad6-466e-b0bd-8419301c973f/101121-amr-chest-ss-1-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/2e74c4fd-649a-4221-b46e-854fecb20b0c\" height=\"200\" width=\"100%\" title=\"Carbapenem Resistance Revisited: Reassessing Our Antibiotics of Choice\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Join Marin H. Kollef, MD in the first of 3 recap podcasts taken from our live event, “The Plot (and Sputum) Thickens: Encountering Carbapenem Resistance in Critically Ill Patients” to learn how to optimize antimicrobial regimens and develop evidence-based antibiotic management plans for complex infections caused by carbapenem-resistant bacteria. This episode covers reassessment of carbapenemases and antibiotic selection."}